Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.
Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.
复制标题
DOI：
10.1016/s0065-2776(06)92006-9
复制
发表时间：
2006
影响因子：
--
通讯作者：
Ploegh HL
中科院分区：
文献类型：
--
作者：
Loureiro J;Ploegh HL
相对较小的基因组和高复制率使病毒和细菌能够积累突变。这不断给宿主免疫系统带来新的挑战。在战壕的另一边，由共同进化历史塑造的日益良好的宿主免疫反应使病原体的生活变得相当复杂。因此，毫不奇怪，病原体要么逃避检测，要么调节宿主的免疫反应，通常是通过将正常的细胞途径重新定向到它们的优势。在本章中，我们主要关注病毒和细菌病原体对I类和II类主要组织相容性复合体（MHC）抗原呈递途径和泛素（Ub）-蛋白酶体系统的操纵。首先，我们描述了抗原呈递途径和Ub‐蛋白酶体系统的一般特征，然后讨论它们如何被病原体操纵。我们讨论了许多人巨细胞病毒（HCMV）编码的免疫调节基因，这些基因干扰抗原呈递（免疫evasins），重点是HCMV免疫evasins US 2和US 11，它们通过催化I类MHC重链从内质网（ER）膜输出到胞质溶胶中，诱导蛋白酶体降解I类MHC重链，这一过程称为ER脱位。US 2和US 11介导的ER错位颠覆确保了I类MHC分子的蛋白酶体降解，并可能允许HCMV避免被细胞毒性T细胞识别，同时提供了对ER相关降解（ERAD）的一般方面的见解，ERAD被真核细胞用于清除其ER中的缺陷蛋白。我们讨论了US 2和US 11选择的用于人类I类MHC分子的移位和降解的不同途径之间的相似性和差异，以及鼠疱疹病毒（MHV）-68 mK 3免疫evasin用于鼠I类MHC的ER移位的独特途径。我们推测三种病原体利用的错位途径对细胞ER质量控制的影响。此外，我们还讨论了泛素（Ub）-蛋白酶体系统及其在抗原呈递核心中的地位，因为蛋白水解和细胞内运输严重依赖于Ub依赖性过程。我们添加了一些在免疫系统背景下病原体操纵Ub‐蛋白酶体系统的例子，以及宿主-病原体关系的不同方面，如病毒出芽，细菌染色体整合和程序性细胞死亡，仅举几例。最后，我们推测新发现的病原体编码的去泛素化酶（DUBs）及其在调节宿主-病原体相互作用中的假定作用。
Relatively small genomes and high replication rates allow viruses and bacteria to accumulate mutations. This continuously presents the host immune system with new challenges. On the other side of the trenches, an increasingly well‐adjusted host immune response, shaped by coevolutionary history, makes a pathogen's life a rather complicated endeavor. It is, therefore, no surprise that pathogens either escape detection or modulate the host immune response, often by redirecting normal cellular pathways to their advantage. For the purpose of this chapter, we focus mainly on the manipulation of the class I and class II major histocompatibility complex (MHC) antigen presentation pathways and the ubiquitin (Ub)‐proteasome system by both viral and bacterial pathogens. First, we describe the general features of antigen presentation pathways and the Ub‐proteasome system and then address how they are manipulated by pathogens. We discuss the many human cytomegalovirus (HCMV)‐encoded immunomodulatory genes that interfere with antigen presentation (immunoevasins) and focus on the HCMV immunoevasins US2 and US11, which induce the degradation of class I MHC heavy chains by the proteasome by catalyzing their export from the endoplasmic reticulum (ER)‐membrane into the cytosol, a process termed ER dislocation. US2‐ and US11‐mediated subversion of ER dislocation ensures proteasomal degradation of class I MHC molecules and presumably allows HCMV to avoid recognition by cytotoxic T cells, whilst providing insight into general aspects of ER‐associated degradation (ERAD) which is used by eukaryotic cells to purge their ER of defective proteins. We discuss the similarities and differences between the distinct pathways co‐opted by US2 and US11 for dislocation and degradation of human class I MHC molecules and also a putatively distinct pathway utilized by the murine herpes virus (MHV)‐68 mK3 immunoevasin for ER dislocation of murine class I MHC. We speculate on the implications of the three pathogen‐exploited dislocation pathways to cellular ER quality control. Moreover, we discuss the ubiquitin (Ub)‐proteasome system and its position at the core of antigen presentation as proteolysis and intracellular trafficking rely heavily on Ub‐dependent processes. We add a few examples of manipulation of the Ub‐proteasome system by pathogens in the context of the immune system and such diverse aspects of the host–pathogen relationship as virus budding, bacterial chromosome integration, and programmed cell death, to name a few. Finally, we speculate on newly found pathogen‐encoded deubiquitinating enzymes (DUBs) and their putative roles in modulation of host–pathogen interactions.